Literature DB >> 21357717

Regulation of Trypanosoma cruzi-induced myocarditis by programmed death cell receptor 1.

Fredy R S Gutierrez1, Flávia S Mariano, Carlo J F Oliveira, Wander R Pavanelli, Paulo M M Guedes, Grace K Silva, Ana P Campanelli, Cristiane M Milanezi, Miyuki Azuma, Tasuku Honjo, Mauro M Teixeira, Julio C S Aliberti, João S Silva.   

Abstract

Trypanosoma cruzi infection causes intense myocarditis, leading to cardiomyopathy and severe cardiac dysfunction. Protective adaptive immunity depends on balanced signaling through a T cell receptor and coreceptors expressed on the T cell surface. Such coreceptors can trigger stimulatory or inhibitory signals after binding to their ligands in antigen-presenting cells (APC). T. cruzi modulates the expression of coreceptors in lymphocytes after infection. Deregulated inflammation may be due to unbalanced expression of these molecules. Programmed death cell receptor 1 (PD-1) is a negative T cell coreceptor that has been associated with T cell anergy or exhaustion and persistent intracellular infections. We aimed to study the role of PD-1 during T. cruzi-induced acute myocarditis in mice. Cytometry assays showed that PD-1 and its ligands are strongly upregulated in lymphocytes and APC in response to T. cruzi infection in vivo and in vitro. Lymphocytes infiltrating the myocardium exhibited high levels of expression of these molecules. An increased cardiac inflammatory response was found in mice treated with blocking antibodies against PD-1, PD-L1, and to a lesser extent, PD-L2, compared to that found in mice treated with rat IgG. Similar results in PD-1(-/-) mice were obtained. Moreover, the PD-1 blockade/deficiency led to reduced parasitemia and tissue parasitism but increased mortality. These results suggest the participation of a PD-1 signaling pathway in the control of acute myocarditis induced by T. cruzi and provide additional insight into the regulatory mechanisms in the pathogenesis of Chagas' disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21357717      PMCID: PMC3088162          DOI: 10.1128/IAI.01047-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion.

Authors:  H Dong; G Zhu; K Tamada; L Chen
Journal:  Nat Med       Date:  1999-12       Impact factor: 53.440

2.  PD-1: an inhibitory immunoreceptor involved in peripheral tolerance.

Authors:  H Nishimura; T Honjo
Journal:  Trends Immunol       Date:  2001-05       Impact factor: 16.687

Review 3.  Chemokines, inflammation and Trypanosoma cruzi infection.

Authors:  Mauro M Teixeira; Ricardo T Gazzinelli; João S Silva
Journal:  Trends Parasitol       Date:  2002-06

Review 4.  The pathogenesis of Chagas' disease: when autoimmune and parasite-specific immune responses meet.

Authors:  M B Soares; L Pontes-De-Carvalho; R Ribeiro-Dos-Santos
Journal:  An Acad Bras Cienc       Date:  2001-12       Impact factor: 1.753

5.  Role played by the programmed death-1-programmed death ligand pathway during innate immunity against Mycobacterium tuberculosis.

Authors:  Ivana B Alvarez; Virginia Pasquinelli; Javier O Jurado; Eduardo Abbate; Rosa M Musella; Silvia S de la Barrera; Verónica E García
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

6.  PD-L2 is a second ligand for PD-1 and inhibits T cell activation.

Authors:  Y Latchman; C R Wood; T Chernova; D Chaudhary; M Borde; I Chernova; Y Iwai; A J Long; J A Brown; R Nunes; E A Greenfield; K Bourque; V A Boussiotis; L L Carter; B M Carreno; N Malenkovich; H Nishimura; T Okazaki; T Honjo; A H Sharpe; G J Freeman
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

Review 7.  The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses.

Authors:  Beatriz M Carreno; Mary Collins
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

8.  Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response.

Authors:  J A S Gomes; L M G Bahia-Oliveira; M O C Rocha; O A Martins-Filho; G Gazzinelli; R Correa-Oliveira
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

9.  Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.

Authors:  Yoshiko Iwai; Masayoshi Ishida; Yoshimasa Tanaka; Taku Okazaki; Tasuku Honjo; Nagahiro Minato
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-06       Impact factor: 11.205

10.  PD-1 inhibits antiviral immunity at the effector phase in the liver.

Authors:  Yoshiko Iwai; Seigo Terawaki; Masaya Ikegawa; Taku Okazaki; Tasuku Honjo
Journal:  J Exp Med       Date:  2003-07-07       Impact factor: 14.307

View more
  29 in total

Review 1.  CD8+ T cells in Trypanosoma cruzi infection.

Authors:  Rick L Tarleton
Journal:  Semin Immunopathol       Date:  2015-04-29       Impact factor: 9.623

2.  Trypanosoma cruzi invades host cells through the activation of endothelin and bradykinin receptors: a converging pathway leading to chagasic vasculopathy.

Authors:  Daniele Andrade; Rafaela Serra; Erik Svensjö; Ana Paula C Lima; Erivan S Ramos; Fabio S Fortes; Ana Carolina F Morandini; Verônica Morandi; Maria de N Soeiro; Herbert B Tanowitz; Julio Scharfstein
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

3.  Induction of Inhibitory Receptors on T Cells During Plasmodium vivax Malaria Impairs Cytokine Production.

Authors:  Pedro A C Costa; Fabiana M S Leoratti; Maria M Figueiredo; Mauro S Tada; Dhelio B Pereira; Caroline Junqueira; Irene S Soares; Daniel L Barber; Ricardo T Gazzinelli; Lis R V Antonelli
Journal:  J Infect Dis       Date:  2015-05-27       Impact factor: 5.226

4.  Role of the PD-1/PD-L1 Pathway in Experimental Trypanosoma cruzi Infection and Potential Therapeutic Options.

Authors:  Yanina Arana; Rosa Isela Gálvez; Thomas Jacobs
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

Review 5.  The heart of the matter: protection of the myocardium from T cells.

Authors:  Andrew H Lichtman
Journal:  J Autoimmun       Date:  2013-06-28       Impact factor: 7.094

6.  Different parasite inocula determine the modulation of the immune response and outcome of experimental Trypanosoma cruzi infection.

Authors:  Diego C Borges; Natalia M Araújo; Cristina R Cardoso; Javier E Lazo Chica
Journal:  Immunology       Date:  2013-02       Impact factor: 7.397

7.  Human leucocyte antigen-G (HLA-G) and its murine functional homolog Qa2 in the Trypanosoma cruzi Infection.

Authors:  Fabrício C Dias; Celso T Mendes-Junior; Maria C Silva; Fabrine S M Tristão; Renata Dellalibera-Joviliano; Philippe Moreau; Edson G Soares; Jean G Menezes; André Schmidt; Roberto O Dantas; José A Marin-Neto; João S Silva; Eduardo A Donadi
Journal:  Mediators Inflamm       Date:  2015-01-20       Impact factor: 4.711

8.  Inhibitory receptors are expressed by Trypanosoma cruzi-specific effector T cells and in hearts of subjects with chronic Chagas disease.

Authors:  Rafael J Argüello; María C Albareda; María G Alvarez; Graciela Bertocchi; Alejandro H Armenti; Carlos Vigliano; Patricia C Meckert; Rick L Tarleton; Susana A Laucella
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

Review 9.  Impairment of T cell function in parasitic infections.

Authors:  Vasco Rodrigues; Anabela Cordeiro-da-Silva; Mireille Laforge; Ali Ouaissi; Khadija Akharid; Ricardo Silvestre; Jérôme Estaquier
Journal:  PLoS Negl Trop Dis       Date:  2014-02-13

10.  PD-1 modulates steady-state and infection-induced IL-10 production in vivo.

Authors:  Cortez McBerry; Alexandra Dias; Nathaniel Shryock; Kristin Lampe; Fredy R S Gutierrez; Louis Boon; R Herbert De'Broski; Julio Aliberti
Journal:  Eur J Immunol       Date:  2013-12-02       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.